Shanghai Lily & Beauty Cosmetics Co Ltd
SSE:605136
Shanghai Lily & Beauty Cosmetics Co Ltd
SSE:605136
Price:
7.45 CNY
0.68%
Market Closed
Updated:
May 17, 2024
Balance Sheet
Balance Sheet Decomposition
Shanghai Lily & Beauty Cosmetics Co Ltd
Shanghai Lily & Beauty Cosmetics Co Ltd
| Current Assets | 2.6B |
| Cash & Short-Term Investments | 1.1B |
| Receivables | 457.2m |
| Other Current Assets | 1B |
| Non-Current Assets | 415m |
| Long-Term Investments | 259.8m |
| PP&E | 55.1m |
| Intangibles | 854k |
| Other Non-Current Assets | 99.2m |
| Current Liabilities | 500.4m |
| Accounts Payable | 117.6m |
| Accrued Liabilities | 109m |
| Short-Term Debt | 237.1m |
| Other Current Liabilities | 36.7m |
| Non-Current Liabilities | 17.2m |
| Long-Term Debt | 15.2m |
| Other Non-Current Liabilities | 2m |
Balance Sheet
Shanghai Lily & Beauty Cosmetics Co Ltd
Shanghai Lily & Beauty Cosmetics Co Ltd
Currency: CNY
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
518
|
584
|
851
|
1 393
|
1 068
|
999
|
1 148
|
|
| Cash |
0
|
0
|
0
|
0
|
1 068
|
999
|
1 148
|
|
| Cash Equivalents |
518
|
584
|
851
|
1 393
|
0
|
1
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
442
|
681
|
579
|
611
|
539
|
393
|
457
|
|
| Accounts Receivables |
79
|
133
|
83
|
142
|
141
|
83
|
54
|
|
| Other Receivables |
363
|
549
|
496
|
470
|
398
|
310
|
404
|
|
| Inventory |
365
|
580
|
517
|
845
|
1 261
|
1 123
|
885
|
|
| Other Current Assets |
82
|
194
|
190
|
162
|
253
|
293
|
143
|
|
| Total Current Assets |
1 407
|
2 039
|
2 138
|
3 012
|
3 121
|
2 809
|
2 633
|
|
| PP&E Net |
5
|
5
|
28
|
31
|
80
|
68
|
55
|
|
| PP&E Gross |
5
|
5
|
28
|
31
|
80
|
68
|
55
|
|
| Accumulated Depreciation |
7
|
10
|
12
|
10
|
20
|
35
|
48
|
|
| Intangible Assets |
3
|
3
|
2
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
19
|
|
| Long-Term Investments |
219
|
13
|
22
|
35
|
173
|
208
|
260
|
|
| Other Long-Term Assets |
26
|
44
|
36
|
36
|
58
|
96
|
81
|
|
| Total Assets |
1 660
N/A
|
2 103
+27%
|
2 225
+6%
|
3 115
+40%
|
3 434
+10%
|
3 181
-7%
|
3 048
-4%
|
|
| Liabilities | ||||||||
| Accounts Payable |
288
|
419
|
334
|
262
|
164
|
136
|
118
|
|
| Accrued Liabilities |
234
|
109
|
116
|
157
|
80
|
102
|
109
|
|
| Short-Term Debt |
22
|
168
|
68
|
194
|
285
|
377
|
237
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
11
|
13
|
12
|
|
| Other Current Liabilities |
74
|
112
|
126
|
168
|
168
|
28
|
25
|
|
| Total Current Liabilities |
617
|
808
|
644
|
781
|
709
|
655
|
500
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
35
|
24
|
15
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Minority Interest |
2
|
3
|
3
|
5
|
1
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
616
N/A
|
805
+31%
|
641
-20%
|
776
+21%
|
743
-4%
|
682
-8%
|
518
-24%
|
|
| Equity | ||||||||
| Common Stock |
360
|
360
|
360
|
400
|
402
|
400
|
400
|
|
| Retained Earnings |
345
|
597
|
882
|
1 221
|
1 560
|
1 336
|
1 366
|
|
| Additional Paid In Capital |
339
|
339
|
339
|
719
|
759
|
757
|
757
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
29
|
0
|
0
|
|
| Other Equity |
0
|
2
|
4
|
1
|
1
|
5
|
6
|
|
| Total Equity |
1 044
N/A
|
1 298
+24%
|
1 584
+22%
|
2 339
+48%
|
2 691
+15%
|
2 500
-7%
|
2 530
+1%
|
|
| Total Liabilities & Equity |
1 660
N/A
|
2 103
+27%
|
2 225
+6%
|
3 115
+40%
|
3 434
+10%
|
3 181
-7%
|
3 048
-4%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
360
|
360
|
360
|
400
|
400
|
400
|
400
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
